Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens-Uwe Peters

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Topics in Medicinal Chemistry|March 14, 2007
11 Years of cyanopyrrolidines as DPP-IV inhibitorsJens-Uwe Peters
Journal of Medicinal Chemistry|August 8, 2013
Polypharmacology - foe or friend?Jens-Uwe Peters
Current Topics in Medicinal Chemistry|December 27, 2005
Inhibitors of dipeptidyl peptidase IV--recent advances and structural viewsDaniel Hunziker, Michael Hennig, Jens-Uwe Peters
Chemmedchem|March 7, 2009
Pharmacological promiscuity: dependence on compound properties and target specificity in a set of recent Roche compoundsJens-Uwe Peters, Patrick Schnider, Patrizio Mattei, et al.
Chemical Communications (Cambridge, England)|April 22, 2003
Iminium ion catalysis: use of the alpha-effect in the acceleration of the Diels-Alder reactionJulie L Cavill, Jens-Uwe Peters, Nicholas C O Tomkinson
Bioorganic & Medicinal Chemistry Letters|November 14, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetrationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Chimia|December 4, 2023
Details Matter in Structure-based Drug DesignBernd Kuhn, Jens-Uwe Peters, Markus G Rudolph, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Novel orally active, dibenzazepinone-based gamma-secretase inhibitorsJens-Uwe Peters, Guido Galley, Helmut Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Aminomethylpyridines as DPP-IV inhibitorsJens-Uwe Peters, Silja Weber, Stéphane Kritter, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Topics in Medicinal Chemistry|March 14, 2007
11 Years of cyanopyrrolidines as DPP-IV inhibitorsJens-Uwe Peters
Journal of Medicinal Chemistry|August 8, 2013
Polypharmacology - foe or friend?Jens-Uwe Peters
Current Topics in Medicinal Chemistry|December 27, 2005
Inhibitors of dipeptidyl peptidase IV--recent advances and structural viewsDaniel Hunziker, Michael Hennig, Jens-Uwe Peters
Chemmedchem|March 7, 2009
Pharmacological promiscuity: dependence on compound properties and target specificity in a set of recent Roche compoundsJens-Uwe Peters, Patrick Schnider, Patrizio Mattei, et al.
Chemical Communications (Cambridge, England)|April 22, 2003
Iminium ion catalysis: use of the alpha-effect in the acceleration of the Diels-Alder reactionJulie L Cavill, Jens-Uwe Peters, Nicholas C O Tomkinson
Bioorganic & Medicinal Chemistry Letters|November 14, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: structure-activity relationship elucidationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: optimising brain penetrationJens-Uwe Peters, Thomas Lübbers, Alexander Alanine, et al.
Chimia|December 4, 2023
Details Matter in Structure-based Drug DesignBernd Kuhn, Jens-Uwe Peters, Markus G Rudolph, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Novel orally active, dibenzazepinone-based gamma-secretase inhibitorsJens-Uwe Peters, Guido Galley, Helmut Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
Aminomethylpyridines as DPP-IV inhibitorsJens-Uwe Peters, Silja Weber, Stéphane Kritter, et al.
Pageof 3